SRC VB VECTOR’s specialists took part in the Annual International Convention BIO 2004 (San-Francisco, USA) in June, 2004.

Owing to participation in this respectable Convention VECTOR’s specialists received plenty of useful information concerning biotechnology development modern trends in the United States and made new contacts with the foreign companies’ representatives.

SRC VB VECTOR’s specialists took part in the Annual International Convention BIO 2004 (San-Francisco, USA) in June, 2004.

Owing to participation in this respectable Convention VECTOR’s specialists received plenty of useful information concerning biotechnology development modern trends in the United States and made new contacts with the foreign companies’ representatives.

Siberian scientists took part in the several workshops and round tables to discuss Russian biotechnology courses of development.

During the negotiations with the CIMIT representatives organized by Jason Rao (Director, BioIndustry Initiative, US Department of State) an agreement about financing opportunities of a number of SRC VB VECTOR’s projects in biomedical research (immunostimulating and anticancer drugs) was reached.

Negotiations with the Dow Chemical Company (San Diego, USA) were devoted to preparation and realization of the collaborative project in new generation vaccines’ development (against influenza and tuberculosis).

Delegates work’s major result was the strengthening of ties and the following collaboration with the US and EC companies, and Russian biotechnology organizations.

SRC VB VECTOR Administration and Convention participants express special thanks to Dr. Jason E. Rao (Director, BioIndustry Initiative, USA); Maria Douglass; CIMIT representatives: Prof. Jeffrey A.Gelfand, Dr.Timothy Brauuns, Dr. Alex Nivorozhkin; CRDF representatives: Jessica Kaplan, Lisa Hilton and to main ISTC projects’ supervisor Natalia Savinova for great support in organizing Russian and CIS representatives’ participation in the Annual International Convention BIO 2004 and for organizing important to VECTOR’s specialists meetings.